Companies Special Situations Explorer About

Board of Directors

Director information for JADE BIOSCIENCES INC (data for year 2026)

Name	Position	Age	Qualifications and Experience	Committee Memberships	Filing Year
Andrew King	Executive Officer	47	["Served as Chief Scientific Officer and Head of Research and Development at Jade","Chief Scientific Officer at Chinook Therapeutics","Head of Renal Discovery and Translational Medicine at Chinook Therapeutics","Executive Vice President of Discovery at BIOAGE Labs","Senior Director of Discovery and Translational Biology at Ardelyx, Inc.","Principal Research Scientist at AbbVie Inc.","Led the Renal Discovery scientific strategy at AbbVie"]	[]	2026
Brad Dahms	Executive Officer	38	["Chief Financial Officer and Treasurer since July 2025","CFO and Chief Business Officer of IDRx, Inc., March 2024 - February 2025","CFO of Theseus Pharmaceuticals, Inc., May 2021 - February 2024","CFO of Selecta Biosciences Inc., September 2019 - May 2021","Senior Vice President—Healthcare Investment Banking at Cantor Fitzgerald & Co., April 2014 - August 2019","Analyst at RBC Capital Markets, 2012 - 2014","Analyst at JPMorgan Chase & Co., 2010 - 2012","Bachelor of Science degree in Economics from The Ohio State University"]	[]	2026
Christopher Cain, Ph.D.	Director of Research, Fairmount Funds Management LLC	42	[]	["Compensation Committee","Nominating & Corporate Governance Committee"]	2026
Eric Dobmeier, J.D.	Venture Partner, Samsara BioCapital	57	[]	["Audit Committee","Nominating & Corporate Governance Committee"]	2026
Erin Lavelle	Former COO and CFO, ProfoundBio and Eliem Therapeutics; Director	48	[]	["Audit Committee","Compensation Committee"]	2026
Lawrence Klein, Ph.D.	CEO of Oruka Therapeutics	43	[]	["Audit Committee","Nominating & Corporate Governance Committee"]	2026
Tomas Kiselak	Founding Partner, Fairmount Funds Management LLC; Director	39	[]	["Compensation Committee"]	2026
Tom Frohlich	CEO and President of Jade Biosciences, Inc.	50	[]	[]	2026